Enter the game-changing implant technology that’s transforming sleep apnea treatment. Two notable options have emerged: Genio Nyxoah and Inspire. These devices offer a novel approach to managing ...

Inspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates. The sleep apnea device maker expects second quarter sales to be 30% ...

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $231.12, a high ...

In a report released today, Brett Fishbin from KeyBanc maintained a Buy rating on Inspire Medical Systems (INSP – Research Report), with a ...

Following weight loss, these patients could become more likely to benefit from Inspire. All in all, the population of people diagnosed with sleep apnea is very large, and we believe Inspire is ...

Wells Fargo analyst Larry Biegelsen maintained a Hold rating on Inspire Medical Systems (INSP – Research Report) yesterday and set a price ...

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists ...